129 related articles for article (PubMed ID: 17569001)
1. Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data.
Kramar F; Zemanova Z; Michalova K; Babicka L; Ransdorfova S; Hrabal P; Kozler P
J Neurooncol; 2007 Sep; 84(2):201-11. PubMed ID: 17569001
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic stratification of recurrent oligodendrogliomas: utility of interphase fluorescence in situ hybridization (I-FISH).
Zemanová Z; Kramar F; Babická L; Ransdorfová S; Melichercíková J; Hrabal P; Kozler P; Michalová K
Folia Biol (Praha); 2006; 52(3):71-8. PubMed ID: 17089917
[TBL] [Abstract][Full Text] [Related]
3. [Molecular cytogenetic analysis of chromosomal aberrations in cells of low grade gliomas and its contribution for tumour classification].
Lhotská H; Zemanová Z; Kramář F; Lizcová L; Svobodová K; Ransdorfová S; Bystřická D; Krejčík Z; Hrabal P; Dohnalová A; Kaiser M; Michalová K
Klin Onkol; 2014; 27(3):183-91. PubMed ID: 24918277
[TBL] [Abstract][Full Text] [Related]
4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
5. Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors.
Boulay JL; Miserez AR; Zweifel C; Sivasankaran B; Kana V; Ghaffari A; Luyken C; Sabel M; Zerrouqi A; Wasner M; Van Meir E; Tolnay M; Reifenberger G; Merlo A
PLoS One; 2007 Jun; 2(6):e576. PubMed ID: 17593975
[TBL] [Abstract][Full Text] [Related]
6. Automatized assessment of 1p36-19q13 status in gliomas by interphase FISH assay on touch imprints of frozen tumours.
Belaud-Rotureau MA; Meunier N; Eimer S; Vital A; Loiseau H; Merlio JP
Acta Neuropathol; 2006 Mar; 111(3):255-63. PubMed ID: 16453145
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of chromosome 1p and 19q deletions in glial tumours by interphase FISH on formalin-fixed paraffin-embedded tissue.
Gonzales M; Dale S; Susman M; Mills J
J Clin Neurosci; 2006 Jan; 13(1):96-101. PubMed ID: 16410204
[TBL] [Abstract][Full Text] [Related]
8. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
Smith JS; Alderete B; Minn Y; Borell TJ; Perry A; Mohapatra G; Hosek SM; Kimmel D; O'Fallon J; Yates A; Feuerstein BG; Burger PC; Scheithauer BW; Jenkins RB
Oncogene; 1999 Jul; 18(28):4144-52. PubMed ID: 10435596
[TBL] [Abstract][Full Text] [Related]
9. Copy number alterations of the polycomb gene BMI1 in gliomas.
Häyry V; Tanner M; Blom T; Tynninen O; Roselli A; Ollikainen M; Sariola H; Wartiovaara K; Nupponen NN
Acta Neuropathol; 2008 Jul; 116(1):97-102. PubMed ID: 18427816
[TBL] [Abstract][Full Text] [Related]
10. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
[TBL] [Abstract][Full Text] [Related]
11. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.
Ino Y; Zlatescu MC; Sasaki H; Macdonald DR; Stemmer-Rachamimov AO; Jhung S; Ramsay DA; von Deimling A; Louis DN; Cairncross JG
J Neurosurg; 2000 Jun; 92(6):983-90. PubMed ID: 10839259
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the TP53 gene in human gliomas.
Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
[TBL] [Abstract][Full Text] [Related]
13. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.
Dreyling MH; Bohlander SK; Adeyanju MO; Olopade OI
Cancer Res; 1995 Mar; 55(5):984-8. PubMed ID: 7867008
[TBL] [Abstract][Full Text] [Related]
14. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
15. Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry).
Kasai H; Kawamoto K
Noshuyo Byori; 1995 Mar; 12(1):75-82. PubMed ID: 7795734
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic analysis of gliomas by in situ hybridization of stereotactic biopsy material.
Lippitz BE; Scheitinger C; Scholz M; Weis J; Gilsbach JM; Füzesi L
Acta Neurochir (Wien); 1997; 139(1):22-5. PubMed ID: 9059707
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines.
Law ME; Templeton KL; Kitange G; Smith J; Misra A; Feuerstein BG; Jenkins RB
Cancer Genet Cytogenet; 2005 Jul; 160(1):1-14. PubMed ID: 15949564
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.
Mariani L; Deiana G; Vassella E; Fathi AR; Murtin C; Arnold M; Vajtai I; Weis J; Siegenthaler P; Schobesberger M; Reinert MM
J Clin Oncol; 2006 Oct; 24(29):4758-63. PubMed ID: 16966689
[TBL] [Abstract][Full Text] [Related]
19. Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas.
Zhao LL; Xu KL; Wang SW; Hu BL; Chen LR
Histopathology; 2012 Oct; 61(4):726-36. PubMed ID: 22978472
[TBL] [Abstract][Full Text] [Related]
20. C-MET overexpression and amplification in gliomas.
Kwak Y; Kim SI; Park CK; Paek SH; Lee ST; Park SH
Int J Clin Exp Pathol; 2015; 8(11):14932-8. PubMed ID: 26823824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
